- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07942636
EMST 150 Training in Mild-Moderate OSA
Evaluating the Efficacy and Feasibility of Combined Expiratory Muscle Strength Training (EMST 150) and Oropharyngeal Myofunctional Therapy in Patients With Mild-to-Moderate Obstructive Sleep Apnea.
Obstructive Sleep Apnea is a condition in which the upper airway repeatedly becomes blocked during sleep, often due to weakness or collapse of the upper airway throat muscles. The purpose of this study is to evaluate whether combining a handheld breathing device (Expiratory Muscle Strength Training (EMST 150)) with structured, speech-language pathology-Guided mouth and throat exercises can help strengthen the muscles that keep the airway open, reduce snoring, and reduce sleep apnea severity while improving overall sleep quality. Participation in this study will last about 3 months. This includes a 5-week home breathing exercise program, two in-person clinic visits (at the beginning of the study and at Month 3), and two short phone check-ins.
Descripción general del estudio
Estado
Condiciones
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Thomaz Fleury Curado, MD
- Número de teléfono: 216-844-1716
- Correo electrónico: thomaz.fleurycurado@uhhospitals.org
Ubicaciones de estudio
-
-
Ohio
-
Cleveland, Ohio, Estados Unidos, 44106
- University Hospitals Cleveland Medical Center
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Clinical diagnosis of Mild-to-Moderate OSA (5<AHI<30 events/hour)
- Patient willingness and physical capability to perform threshold-based respiratory exercises and daily oral myofunctional exercises.
- Documented failure, intolerance (defined as regular use < 4 hours/night), or patient refusal of standard therapies, including Continuous Positive Airway Pressure (CPAP) and surgical interventions.
Exclusion Criteria:
- Severe OSA (AHI>30 events/hour)
- Active asthma, severe or poorly controlled asthma with low symptom perception, or severe chronic obstructive pulmonary disease (COPD)
- Uncontrolled hypertension, defined as resting systolic blood pressure >160 mmHg or diastolic blood pressure >100 mmHg at screening, or any change in antihypertensive medication within the past 30 days, or significant cardiovascular disease.
- Recent esophageal surgery, recent abdominal surgery, or presence of an abdominal hernia.
- History of spontaneous pneumothorax, or incomplete recovery/healing following traumatic pneumothorax or rib fracture.
- History of lung transplantation or lung resection.
- Current tracheostomy or unhealed tracheostomy stoma.
- Presence of a cerebrospinal fluid (CSF) drain or active intracranial pressure monitoring.
- Active epistaxis (frequent/severe nosebleeds) or active hemoptysis within the past 30 days.
- Tympanic membrane perforation (ruptured eardrum) or active inner/middle ear pathology.
- Unrelated or uncontrolled gastroesophageal reflux disease (GERD).
- Known or suspected pregnancy.
- Active use of CPAP, mandibular advancement device (MAD), or hypoglossal nerve stimulation (HGNS) during the study period.
- Any acute medical condition or clinical situation where generating intrathoracic, intro-abdominal, or intracranial pressure (similar to Valsalva maneuver) is clinically contraindicated.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Participants with Obstructive Sleep Apnea (OSA)
Adult participants diagnosed with mild-to-moderate obstructive OSA. |
Participants utilize the EMST 150 device to strengthen expiratory and upper airway musculature. During training, participants inhale deeply and exhale forcefully through the mouthpiece again calibrated resistance while maintaining an airtight lip seal to overcome the target threshold pressure. Participants perform structured oral motor exercises :
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI)
Periodo de tiempo: Baseline, 3 months
|
The Pittsburgh Sleep Quality Index (PSQI) is a 19-item self-report questionnaire that evaluates overall sleep quality and disturbances over a one-month time interval. With higher scores indicating poor sleep quality. |
Baseline, 3 months
|
|
Change in Daytime sleepiness as measured by the Epworth Sleepiness Scale (ESS)
Periodo de tiempo: Baseline, 3 months
|
The Epworth Sleepiness Scale (ESS) is a short, self-administered questionnaire used to measure a person's general level of daytime sleepiness and likelihood of dozing off in everyday situations. Scored on a scale from 0 would never doze, to 3 high chance of dozing. |
Baseline, 3 months
|
|
Snore score as measured by smartphone application monitoring.
Periodo de tiempo: Up to 3 months
|
Smartphone application monitoring (Snorelab) will be used to track longitudinal acoustic changes in nightly snoring. The application analyzes breathing sounds to compute aggregate acoustic metrics. |
Up to 3 months
|
|
Percentage of snoring sleep time as measured by smartphone application monitoring.
Periodo de tiempo: Up to 3 months
|
Smartphone application monitoring (Snorelab) will be used to track longitudinal acoustic changes in nightly snoring. The application analyzes breathing sounds to compute aggregate acoustic metrics. |
Up to 3 months
|
|
Noise intensity in decibels as measured by smartphone application monitoring.
Periodo de tiempo: Up to 3 months
|
Smartphone application monitoring (Snorelab) will be used to track longitudinal acoustic changes in nightly snoring. The application analyzes breathing sounds to compute aggregate acoustic metrics. |
Up to 3 months
|
|
Change in Isometric maximal tongue pressure (kPa) as measured by the Iowa Oral Performance Instrument (IOPI)
Periodo de tiempo: Baseline, 3 months
|
The Iowa Oral Performance Instrument (IOPI) is a portable, evidence-based medical device used to objectively measure, document, and train lip and tongue strength and endurance. The device digitally records maximum isometric pressure in kilopascals |
Baseline, 3 months
|
|
Change in tongue muscle endurance as measured by time in seconds sustained at 50% maximal pressure.
Periodo de tiempo: Baseline, 3 months
|
Time in seconds sustained at 50% maximal pressure. |
Baseline, 3 months
|
|
Change in Apnea-Hypopnea Index (AHI)
Periodo de tiempo: Baseline, 3 months
|
The apnea-hypopnea index (AHI) is the average number of breathing pauses (apneas) and shallow breathing events (hypopneas) that occur per hour of sleep, with higher scores indicating greater sleep apnea severity. |
Baseline, 3 months
|
|
Change in Maximum Expiratory Pressure (MEP)
Periodo de tiempo: Baseline, 3 months
|
MEP is the highest positive pressure generated by a person during a forced exhalation against a blocked airway. It measures the strength of the expiratory muscles, including the abdominal and internal intercostal muscles, and helps evaluate cough efficiency and neuromuscular function. Lower scores indicate generalized respiratory muscle weakness, chronic obstructive pulmonary disease (COPD), or neuromuscular conditions like myasthenia gravis or Guillain-Barré syndrome. |
Baseline, 3 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Thomaz Fleury Curado, MD, University Hospitals Cleveland Medical Center
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- STUDY20261102
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .